<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05058326</url>
  </required_header>
  <id_info>
    <org_study_id>052020</org_study_id>
    <nct_id>NCT05058326</nct_id>
  </id_info>
  <brief_title>Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women</brief_title>
  <acronym>MANOPRESS</acronym>
  <official_title>Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to stablish a correlation between fecal incontinence severity&#xD;
      scales (Wexner &amp; St. Mark's) and manometric values obtained using the Anopress® portable&#xD;
      manometry and values obtained using endoanal ultrasound in women with fecal incontinence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Anopress® portable anal manometry will be used to measure the pressures of the anal canal&#xD;
      in different phases: rest, squeeze, strain and endurance.&#xD;
&#xD;
      All female patients referred with the diagnosis of fecal incontinence giving written informed&#xD;
      consent will undergo a endoanal portable manometry at our outpatients clinics. They will be&#xD;
      asked to fill out the severity questionaries (Sant Mark's and Wexner). All data will be&#xD;
      collected for analysis.&#xD;
&#xD;
      An endoanal ultrasound will be performed in all patients to assess the sphincter integrity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>18 Months</target_duration>
  <primary_outcome>
    <measure>Stablish a correlation between Wexner fecal incontinence severity scales and manometric values obtained using the Anopress® portable manometry in women with fecal incontinence</measure>
    <time_frame>During the procedure</time_frame>
    <description>Spearman and Pearson correlation will be used to assess correlations between values</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stablish a correlation between St. Mark's fecal incontinence severity scales and manometric values obtained using the Anopress® portable manometry in women with fecal incontinence</measure>
    <time_frame>During the procedure</time_frame>
    <description>Spearman and Pearson correlation will be used to assess correlations between values</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stablish a correlation between St.Mark's fecal incontinence severity scales and values obtained using endoanal ultrasound in women with fecal incontinence</measure>
    <time_frame>During the procedure</time_frame>
    <description>Spearman and Pearson correlation will be used to assess correlations between values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stablish a correlation between Wexner fecal incontinence severity scales and values obtained using endoanal ultrasound in women with fecal incontinence</measure>
    <time_frame>During the procedure</time_frame>
    <description>Spearman and Pearson correlation will be used to assess correlations between values</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Fecal Incontinence</condition>
  <condition>Anal; Sphincter, Incontinence</condition>
  <condition>Incontinence, Urge</condition>
  <arm_group>
    <arm_group_label>TEST GROUP</arm_group_label>
    <description>Women with fecal incontinence referred to outpatients clinic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Portable endoanal manometry</intervention_name>
    <description>Endoanal manometry values will be obtained using de Anopress® device. Fecal incontinence severity questionaries will be filled and collected.</description>
    <arm_group_label>TEST GROUP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endoanal ultrasound</intervention_name>
    <description>To assess the integrity of the anal canal.</description>
    <arm_group_label>TEST GROUP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Incontinence severity scale questionaires</intervention_name>
    <description>Wexner and St. Mark's scales.</description>
    <arm_group_label>TEST GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women over 18 years referred to our outpatient's clinic with the clinical diagnosis of&#xD;
        fecal incontinence.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with the clinical diagnosis of fecal incontinence&#xD;
&#xD;
          -  Age ≥ 18 years.&#xD;
&#xD;
          -  Informed consent signed by the patient and the researcher.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with psychiatric illnesses, addictions or any disorder that prevents&#xD;
             understanding of the study.&#xD;
&#xD;
          -  Inability to read or understand the questionnaires.&#xD;
&#xD;
          -  Inability to read or understand any of the informed consent languages (Catalan,&#xD;
             Spanish).&#xD;
&#xD;
          -  Any patient who, due to his medical characteristics, presents a high individual risk&#xD;
             when being included and completing the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ander Timoteo, MD</last_name>
    <phone>+34972940256</phone>
    <email>atimoteo.girona.ics@gencat.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitari Dr. Josep Trueta de Girona</name>
      <address>
        <city>Girona</city>
        <state>Catalunya</state>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ander Timoteo, MD</last_name>
      <phone>+34 972940256</phone>
      <email>atimoteo.girona.ics@gencat.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 13, 2021</study_first_submitted>
  <study_first_submitted_qc>September 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anal manometry</keyword>
  <keyword>Anal portable manometry</keyword>
  <keyword>Fecal incontinence severity</keyword>
  <keyword>Endoanal ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence, Urge</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

